13
- Societies
- SSH
- Categories
- Session
Workshop Experimental Hematology II
-
A patient avatar system to anticipate therapy sensitivity in clinically challenging lymphomas
- Presentation time:
- 7 min
- Discussion time:
- 3 min
Speaker: Justine Epiney (CHUV)
-
Targeting oncogenic splicing in AML employing a Mesoporus Silica Nanoparticle-based siRNA Delivery
- Presentation time:
- 7 min
- Discussion time:
- 3 min
-
Leveraging protein design for CAR-T cell development from bench to bedside
- Presentation time:
- 7 min
- Discussion time:
- 3 min
-
Modeling CEBPA mutations reveals metabolic vulnerabilities in AML
- Presentation time:
- 7 min
- Discussion time:
- 3 min
Speaker: Claudia Pérez Carretero
-
Role of Myeloid Hexokinase 3 in Shaping Drug Responses in AML Cells
Speaker: Mario P. Tschan (University of Bern)
-
Reconstitution After Transplantation in AML Patients at Single Cell Resolution
Speaker: Evi Vlachou